{
    "clinical_study": {
        "@rank": "142991", 
        "acronym": "ATLANTIS-ACS", 
        "brief_summary": {
            "textblock": "The aims of the study are to:\n\n        -  explore whether platelet reactivity in patients treated wih novel platelet inhibitors\n           is associated with clinical outcome\n\n        -  investigate whether a therapeutic window exist for novel platelet inhibitors\n\n        -  investigate the incidence of adverse events under treatment with novel platelet\n           inhibitors in the real life clinical scenario\n\n        -  investigate the association between genetic polymorphisms, inflammation, platelet\n           reactivity and clinical outcome\n\n        -  investigate synergistic effects between aspirin and novel platelet inhibitors"
        }, 
        "brief_title": "Platelet Function in Patients With an Acute Coronary Syndrome", 
        "condition": "Acute Coronary Syndrome (ACS)", 
        "condition_browse": {
            "mesh_term": "Acute Coronary Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signed informed consent\n\n          -  Acute coronary syndrome at admission\n\n          -  Planned treatment with novel platelet inhibitors\n\n          -  Age >18\n\n        Exclusion Criteria:\n\n        * Participation in interventional trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients presenting with an acute coronary syndrome"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01992484", 
            "org_study_id": "ATLANTIS-ACS"
        }, 
        "intervention_browse": {
            "mesh_term": "Platelet Aggregation Inhibitors"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "platelets, Acute coronary Syndrome (ACS), prasugrel, ticagrelor, aspirin", 
        "lastchanged_date": "November 19, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria"
                }, 
                "name": "Medical Univerity of Vienna, Department of Cardiology"
            }, 
            "investigator": [
                {
                    "last_name": "Jolanta M Siller-Matula, PD MD PhD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Georg Delle-Karth, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_groups": "1", 
        "official_title": "Association Between the Antiplatelet Drug Efficacy/Safety and Platelet Function in Patients Treated With Novel Platelet Inhibitors Due to an Acute Coronary Syndrome", 
        "other_outcome": {
            "measure": "single endpoints of acute coronary syndrome, myocardial infarction, cardiac death, all-cause death, urgent vessel revascularization (PCI or CABG), stroke.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_contact": {
            "email": "jolanta.siller-matula@meduniwien.ac.at", 
            "last_name": "Jolanta M Siller-Matula, PD MD PhD", 
            "phone": "0043 1 404004614"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A composite of MACE and BARC=>2 bleedings.", 
            "measure": "Net clinical benefit.", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01992484"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Jolanta Siller-Matula", 
            "investigator_title": "PD Dr.med. PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "MACE: the composite of stent thrombosis, cardiac death and myocardial infarction.\nMajor Bleeding: BARC =>2, TIMI major, GUSTO moderate-severe-life threatening.", 
            "measure": "MACE and Major bleeding", 
            "safety_issue": "Yes", 
            "time_frame": "1 year"
        }, 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}